Where heart care meets heart science
On a mission
At Prolaio, we're unlocking continuous, predictive and shareable heart data to liberate patients from hospital-based reactive care and accelerate every new therapy.
We aim to transform real‑world heart data into faster discovery today and precision care for functional cures tomorrow.
Leadership team
Challenging the status quo in cardiology
Breakthroughs in new therapies and heart care happen when continuous, high-density data insights replace today’s episodic “snapshot” monitoring - creating important medicine faster and keeping people out of the hospital to eradicate avoidable heart conditions.
Where better futures begin
We are a diverse team of experts in cardiovascular medicine, science, technology, and healthcare, working together to erradicate avoidable heart conditions.
We're hiring—join us!
Recognitions
A new era of heart health innovation:
Prolaio™ + Kardigan™ combination
Prolaio’s high-density data and advanced analytics, combined with Kardigan’s mission to develop multiple targeted medicines in parallel at an unprecedented rate, create a pioneering heart health company to bring people with cardiovascular diseases closer to the cures they deserve.
Tassos Gianakakos, co-founder of both Prolaio and Kardigan, emphasizes:
“Kardigan and Prolaio were both founded to challenge the status quo in cardiology. If we have any shot at radically reducing the time and cost to develop meaningful new medicines and provide better healthcare access and outcomes for patients, we need to fundamentally embrace real-world data and AI-based tools in a way that is fully integrated across R&D. Together, Prolaio and Kardigan are establishing a new heart health company to make this vision a reality.”